In vitro Model for Cryptosporidium parvum Infection

IMMUNO-HISTOCHEMICAL CHANGES TRIGGERED BY REPEATED CRYPTOSPORIDIUM INFECTION IN IMMUNOSUPPRESSED MICE

Gene sequences of TNF and INFα Cytokines in Cryptosporidium Co-infection with H-pylori of irritable bowel syndrome

Prolonged Cryptosporidium Parvum Infection Can Be a Risk Factor for Intestinal Malignancy Even In Immunocompetent Host

IVERMECTIN WITH NITAZOXANIDE ELIMINATE CRYPTOSPORIDIUM INTESTINAL INFECTION IN IMMUNOCOMPROMIZED MICE AND UPREGULATE CYTOKERATIN20 EXPRESSION, ENHANCING INTESTINAL CELLULAR HEALING

DETECTION OF CRYPTOSPORIDIUM-INDUCED INTESTINAL TISSUE ALTERATIONS IN DEXAMETHASONE TREATED & UN-TREATED MICE

EFFECT OF <i>CRYPTOSPORIDIUM PARVUM</i> INFECTION ON DNA DAMAGE AND CYTOKINES GENE EXPRESSION IN BLOOD OF IMMUNOCOMPROMISED MICE

Upregulation of Tissue Transglutaminase in Transforming Growth Factor-b Induced Epithelial Mesenchymal TG2Transdifferentiation In Rat Tubular Epithelial Cells

ROLE OF APOPTOSIS IN EXPERIMENTAL CRYPTOSPORIDIUM PARVUM INFECTED ALBINO MICE

DOWNREGULATION OF TOLL-LIKE RECEPTOR 4 AND ACUTE PHASE CYTOKINES MEDIATED DEXAMETHASONE IMMUNOSUPPRESSANT MECHANISM DURING CRYPTOSPORIDIUM-PARVUM INFECTION